Health Care/Hospital News & Press Release Distribution

Merck and Ping An Good Doctor Form Strategic Collaboration to Advance Intelligent Healthcare in China

SHANGHAI, Dec. 4, 2019 /PRNewswire/ -- Merck, a leading science and technology company, signed a strategic collaboration agreement today with one of the world's leading healthcare ecosystem platforms, Ping An Healthcare and Technology Company Limited (Stock code: "Ping An Good Doctor", 1833.HK)....

2019-12-04 12:57 7080

Merck and Ping An Good Doctor Form Strategic Collaboration to Advance Intelligent Healthcare in China

TIENS Group Featured on the NASDAQ Screen in New York's Times Square

TIANJIN, China, Dec. 4, 2019 /PRNewswire/ -- TIENS Group, one of the world's leading healthcare companies, appeared on the NASDAQ screen inNew York's Times Square onNovember 18, 2019 to display the charm of Chinese enterprise to the world. T...

2019-12-04 12:05 3077

TIENS Group Featured on the NASDAQ Screen in New York's Times Square

Celebrate 2019 Rice Day with HealthyRicestyle: Jasmine Food Highlights a Fun and Healthy Way to Enjoy Rice

PUCHONG and SELANGOR, Malaysia, Dec. 4, 2019 /PRNewswire/ -- Jasmine Food Corporation ends 2019 Rice Day with successful wrap up of 'HealthyRiceStyle 2019', captivating thousands of visitors to join the rice-related activities at North Court, IOI MallPuchong, Malaysia. Aiming to enrich Malaysian ...

2019-12-04 11:30 19604

Celebrate 2019 Rice Day with HealthyRicestyle: Jasmine Food Highlights a Fun and Healthy Way to Enjoy Rice

Latest International Study Shows Aesthetic Surgery Continues to Rise Worldwide

Total surgical and nonsurgical procedures increased by 5.4% in 2018 HANOVER, New Hampshire, Dec. 4, 2019 /PRNewswire/ -- The International Society of Aesthetic Plastic Surgery (ISAPS) released the results of their annual International Survey on Aesthetic/Cosmetic Procedures today, which showed a...

2019-12-04 01:00 1734

Accor releases thought-leading white paper on the business of wellness and hospitality

In "It's a Wellness World: The Global Shift Shaking up Our Business", Accor's Emlyn Brown explains how exceptional wellness experiences are good for guests, business and the hospitality industry PARIS, Dec. 3, 2019 /PRNewswire/ -- When stepping into a hotel these days, one cannot help but not...

2019-12-03 22:37 1680

PathogenDx Lauded by Frost & Sullivan for Its Game-changing DNA-based Multiplex Microarray Technology

PathogenDx's breakthrough technology shifts the pathogen detection paradigm from microbial to molecular testing through its microarray assays, namely Detect X, EnviroX, and QuantX SANTA CLARA, California, Dec. 3, 2019 /PRNewswire/ -- Based on its recent analysis of the global microbial DNA testin...

2019-12-03 22:00 1232

PathogenDx Lauded by Frost & Sullivan for Its Game-changing DNA-based Multiplex Microarray Technology

North Pole Engineering Releases Runn Smart Treadmill Sensor

MINNEAPOLIS, Dec. 3, 2019 /PRNewswire/ -- North Pole Engineering announces the Runn™ smart treadmill sensor, a wireless speed, incline and cadence sensor for use with virtually any treadmill. Capturing treadmill workout data in real-time, Runn wirelessly communicates with mobile apps and wearable...

2019-12-03 21:50 980

VolitionRx Limited Announces Proof of Concept Data in Lymphoma and Leukemia

AUSTIN, Texas, Dec. 3, 2019 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced results from its latest proof of concept study. A single pre-clinical Nu.Q™ assay utilizing a basic microtiter plate platform detected 80% of newly diagnosed Non-Hodgkins Lymphoma ("N...

2019-12-03 21:30 11632

United Imaging, BAMF Health Bring Bold Vision to Life: Global Strategic Partnership Advances Theranostics and Precision Medicine

HOUSTON, Dec. 3, 2019 /PRNewswire/ -- United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, announced today a global, strategic partnership with BAMF Health, an organization that is achieving AI-enabled precision medicine through molecular imaging and theranostic...

2019-12-03 21:00 960

Ping An Receives Two Awards from Hong Kong Institute of Directors

HONG KONG and SHANGHAI, Dec. 3, 2019 /PRNewswire/ -- Ping An Insurance (Group) Company ofChina, Ltd. (hereafter "Ping An" or the "Group", HKEx:2318; SSE:601318) has received two awards at the Directors Of The Year Awards 2019, organized by the Hong Kong Institute of Directors.Ping An's Board of D...

2019-12-03 20:20 12817

Lumosa Announces FDA Acceptance of IND Application for LT1001, an Extended-Release Analgesic Injection - Lumosa to Initiate the Bridging Study in the US

TAIPEI, Dec. 3, 2019 /PRNewswire/ -- Opioid misuse, addiction, and overdoses have caused significant social and economic burdens leading to the opioid crisis. LT1001 (brand name Naldebain®) is a prodrug of nalbuphine, an abuse-free analgesic that has been marketed worldwide for decades. Naldebain...

2019-12-03 17:36 947

Continuing the Resplendence with 20 Years' Glory, CPhI China Welcomes the Golden Year of Chinese Pharma

SHANGHAI, Dec. 3, 2019 /PRNewswire/ -- As a world-renowned vertical trade and exchange event of the pharmaceutical industry, CPhI & P-MEC China 2020 will take place at Shanghai New International Expo Centre (SNIEC)June 22-24, 2020. The exhibition will reach a scale of 210,000m2, facilitate over 3...

2019-12-03 16:54 1918

Continuing the Resplendence with 20 Years' Glory, CPhI China Welcomes the Golden Year of Chinese Pharma

New Early Breast Cancer Drug Approved by Singapore Health Sciences Authority

* NERLYNX® (neratinib) now approved in Singapore for HER2+ breast cancer patients following adjuvant trastuzumab-based therapy * NERLYNX is the first therapy in the Specialised Therapeutics' portfolio approved inSE Asia * Five-year follow up data show NERLYNX reduces risk of invasive disease...

2019-12-03 05:30 1086

Gowan Company Announces Acquisition of Two New Active Ingredients, Fenamidone and Pencycuron, from Bayer AG

HARPENDEN, England, Dec. 3, 2019 /PRNewswire/ -- Gowan Crop Protection Limited, an affiliate of Gowan Company, L.L.C., announced today that it has entered into agreements with Bayer AG to acquire rights to the active ingredients Fenamidone and Pencycuron. The acquisition includes product regist...

2019-12-03 01:00 1247

Gowan Company Announces Acquisition of Two New Active Ingredients, Fenamidone and Pencycuron, from Bayer AG

Company Expanding its Global Fungicide Portfolio HARPENDEN, England, Dec. 2, 2019 /PRNewswire/ -- Gowan Crop Protection Limited, an affiliate of Gowan Company, L.L.C., announced today that it has entered into agreements with Bayer AG to acquire rights to the active ingredients Fenamidone and P...

2019-12-03 01:00 1225

First Of Its Kind Memory Disorder Prison Unit: Federal Inmates Certified As Certified Nursing Assistants, Federal Correctional Staff Certified With Specialized Certification

The National Council of Certified Dementia Practitioners (NCCDP) credential enables inmate staff with the knowledge and tools necessary to respond to cognitively impaired inmates SPARTA, New Jersey, Dec. 2, 2019 /PRNewswire/ -- The National Council of Certified Dementia Practitioners (NCCDP) cre...

2019-12-02 22:03 1652

CMAB Biopharma and Fapon Biopharma Sign Agreement to Develop and Manufacture a Biologic Oncology Asset

* The newly founded relationship will combine the research and development ingenuity of Fapon Biopharma with the state-of-art biologics manufacturing services offered by CMAB * CMAB will provide a full range of development and manufacturing services for Fapon Biopharma's biologic drug project...

2019-12-02 18:28 2253

CMAB Biopharma and Fapon Biopharma Sign Agreement to Develop and Manufacture a Biologic Oncology Asset

* The newly founded relationship will combine the research and development ingenuity of Fapon Biopharma with the state-of-art biologics manufacturing services offered by CMAB * CMAB will provide a full range of development and manufacturing services for Fapon Biopharma's biologic drug project...

2019-12-02 18:18 1198

Concord Medical Announces Changes to the Board

BEIJING, Dec. 2, 2019 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a specialty hospital management group and an operator of the network of radiotherapy and diagnostic imaging centers inChina, today announced the resignation of Mr. Sha...

2019-12-02 17:39 5322

Innovent Presents Co-developed Cancer-Fighting Tyvyt(R) (Sintilimab Injection) at CIIE 2019 with Eli Lilly

SUZHOU, China, Nov. 28, 2019 /PRNewswire/ -- Innovent Biologics (01801.HK), a multinational biopharmaceutical company, and Eli Lilly and Company presented their co-developed Tyvyt® (generic name: sintilimab injection), a fully human anti-programmed cell death protein 1 (anti-PD-1) monoclonal anti...

2019-12-02 09:37 5063